AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitavolt-M (XR) 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Neomac Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitavolt-M (XR) 50/500 Tablet

Diabex Duo (XR) 50/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex Duo (XR) may be used alone or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported side effects include nausea, diarrhea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; patients should learn hypoglycemia recognition and management. This medication is not universally suitable. Prior to initiating treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Interactions with other medications are possible; provide your doctor with a complete medication list to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Sitavolt-M (XR) 50/500 Tablet

No text provided to rephrase.

Uses of Sitavolt-M (XR) 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Sitavolt-M (XR) 50/500 Tablet:

Follow your doctor's instructions or consult the product label for proper administration. Ingest Sitavolt-M (XR) 50/500 tablets with a meal.

Common Side effects of Sitavolt-M (XR) 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitavolt-M (XR) 50/500 Tablet:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Ingest Sitavolt-M (XR) 50/500 tablets with a meal.

How Sitavolt-M (XR) 50/500 Tablet works:

Sitagliptin and metformin, combined as Sitavolt-M (XR) 50/500 tablets, offer enhanced blood glucose management. Sitagliptin boosts insulin production from the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to superior blood sugar control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitavolt-M (XR) 50/500 Tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitavolt-M (XR) 50/500 tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitavolt-M (XR) 50/500 tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms appear.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitavolt-M (XR) 50/500 Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is essential. For those with severe kidney disease, Sitavolt-M (XR) 50/500 Tablets are contraindicated. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitavolt-M (XR) 50/500 tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitavolt-M (XR) 50/500 Tablet :

Should you forget a dose of Sitavolt-M (XR) 50/500 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitavolt-M (XR) 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitavolt-M (XR) 50/500 Tablet

Sitavolt-M (XR) 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitavolt-M (XR) 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially impacting mental function. To mitigate these risks, supplemental vitamin B12 intake is recommended at least annually, according to some researchers.
Sitavolt-M (XR) 50/500 Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitavolt-M (XR) 50/500 Tablets are contraindicated in patients with known allergies to any of its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitavolt-M (XR) 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Sitavolt-M (XR) 50/500 Tablets can cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitavolt-M (XR) 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitavolt-M (XR) 50/500 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitavolt-M (XR) 50/500 Tablet components or excipients should not use this medication. Its use is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitavolt-M (XR) 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitavolt-M XR 50/500) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention, including discontinuing Sitagliptin/Metformin, if these symptoms occur.
Prolonged Sitavolt-M (XR) 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitavolt-M (XR) 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitavolt-M (XR) 50/500 Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitavolt-M (XR) 50/500 Tablet components or excipients should not use this medication. Its use is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitavolt-M (XR) 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitavolt-M XR 50/500) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitavolt-M (XR) 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, and balance problems), and urinary difficulties, potentially impacting mental state. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sitavolt-M (XR) 50/500 Ta...
136